Chase Feiger, M.D. is the co-founder & CEO of Ostro, a company building AI solutions for large, mid-size, and small life science companies. Previously, Feiger co-founded Parsable and worked in venture capital, investing in 20+ companies.
In the global fight against HIV , a twice-yearly injection could represent a seismic shift in prevention efforts. Lenacapavir , Gilead Sciences’ innovative therapy for HIV pre-exposure prophylaxis , is not only a breakthrough in clinical efficacy but also a model for advancing equitable healthcare access.
It represents a big swing in a competitive space. In late 2021, Viiv Healthcare, owned by GlaxoSmithKline , saw its Apretude . At the time, it became the first long-acting PrEP treatment: the injection was administered as few as six times per year. Lenacapavir cuts the number of needed injections to two, serving as another testament to the power of competition in pharma. When companies compete, innovation thrives – and people benefit.
O'Day, however, saw the bigger picture. He aimed to position Gilead as not only a scientific powerhouse but as an advocate for global health equity. Four years in, the company’s transformation is well underway, with Gilead doubling the breadth of its pipeline, launching six innovative therapies and advancing initiatives designed to redefine the company's role in the healthcare landscape.
For many people, the additional treatment options cannot come soon enough. “We have very effective treatment regimens in the developed world, but about 30% of people that know they have HIV are not virologically suppressed,” O’Day notes. “We talk about having person-centric innovation when it comes to HIV and lenacapavir is a perfect example of that. We're going to have a variety of options to help that 30% of people.
“Behind these numbers there are real people, whose lives have been saved and transformed thanks to the local organizations and programs we are helping to support,” she says.
Health Innovation Gilead Lenacapavir Public Health HIV AIDS Prep Infectious Disease Life Science Innovation
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Elon Musk Rages at Self-Driving CEO Who Dared Criticize Tesla's Troubled 'Full Self-Driving'Science and Technology News and Videos
Read more »
Drowsy Driving: Not Taken as Seriously as Drunk Driving, But It Can KillFolks are more likely to drive drowsy than drive drunk, even though both raise the risk of a fatal crash, a new survey shows.
Read more »
Morgan Stanley found a new autonomous driving pure play, gives it 25% upsideWeRide will benefit from its early-mover advantage in self-driving vehicles, per Morgan Stanley.
Read more »
Winter driving in mountains ahead of snow for Denver's morning commute on MondayJeff is a digital journalist with the Denver7 team.
Read more »
City of Sugar Land explores future with self-driving cable-rail systemSugar Land is collaborating with Swyft Cities to explore the Whoosh® cable transit system, featuring autonomous, gondola-like electric vehicles on elevated cables, aimed at enhancing mobility and sustainability.
Read more »
Tesla, Alphabet or GM? A breakdown of the autonomous driving battle and how to trade itMike Khouw breaks down how autonomous driving will impact Tesla, Alphabet and GM shares.
Read more »